Compare Lynx Therapeutics vs Sorrento Therapeutics
Customers evaluate the quality of Lynx Therapeutics's products using the following success metrics.
Overview
Lynx Therapeutics is 32 yrs old and is based in United States.
Provider of genetic analysis tools for biological research.
Sorrento Therapeutics is based in United States
Sorrento Therapeutics (NASDAQ: SRNE) is a development-stage biopharmaceutical company focused on the discovery, development, and commercialization of proprietary biotherapeutics for the treatment of a variety of disease conditions, including cancer, inflammation, metabolic, and infectious diseases. STI's objective is to identify drug development candidates derived from its proprietary human antibody libraries and, either independently or through partnerships, advance selected targets into preclinical or clinical development.
Demo Video
Leadership
Henry H. Ji (Chief Executive Officer, President)
Investors
Solexa, Downsview Capital
Paycheck Protection Program, QuickByte
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Lynx Therapeutics has not claimed their profile.
Work for Lynx Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Lynx Therapeutics?
Claim your profile now.
Information not available because Sorrento Therapeutics has not claimed their profile.
Work for Sorrento Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Sorrento Therapeutics?
Claim your profile now.